drugset / Trial / NCT07803991
Efficacy and Safety of SYH2069 Injection in Obese Participants Without Diabetes.
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the efficacy and safety of SYH2069 injection compared with placebo in obese Non-diabetic Participants after 28 weeks of treatment.
Timeline
- Start
- 2026-09-01
- Primary completion
- 2027-09-30
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYH2069 | Unknown | 0.6 ml | Subcutaneous |
| Subject | SYH2069 | Unknown | 1.2 ml | Subcutaneous |